About Wize Pharma, Inc.
Wize Pharma, Inc. develops, produces and sells electronic and electro-optical systems. It focuses on treatment of ophthalmic disorders including Dry Eye Syndrome and other inflammatory conditions. The company holds rights to purchase, market, sell and distribute LO2A. Wize Pharma is headquartered in Hod Ha'Sharon, Israel.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.56$ per share.
The book value per share is -0.01$
Create a solid portfolio with WIZP
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|